Dr. Asif Serajian, DO

Dr. Serajian practices at UChicago Medicine AdventHealth GlenOaks in Glendale Heights, Illinois, part of The University of Chicago.

Dr. Serajian's NPI, 1790897049, was assigned on August 31, 2006. Dr. Serajian holds Illinois license 036126138.

Dr. Serajian's primary practice is UChicago Medicine AdventHealth GlenOaks, at 701 Winthrop Avenue, Glendale Heights, IL 60139 in Du Page County. The practice phone is (630) 545-8000.

Dr. Serajian's primary practice is UChicago Medicine AdventHealth GlenOaks in Glendale Heights, Illinois, part of The University of Chicago. Dr. Serajian is also affiliated with Northwestern Medicine Central DuPage Hospital. The medical group on file is UChicago Medicine AdventHealth GlenOaks. Dmand AI also links Dr. Serajian to 3 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Serajian practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Serajian's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Serajian's licenses on file in 2 states: Illinois and Michigan.

CMS data shows 6,918 Medicare services from Dr. Serajian across 52 procedure codes in 2024, for 1,758 Medicare patients. Medicare paid $505,551 for them.

CMS counts 1,758 Medicare patients who saw Dr. Serajian in 2024. The largest group is 75 to 84, with 641 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 28% are also on Medicaid. Their average risk score is 2.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Serajian's median patient age at 71, with 52% women.

In 2024, Dr. Serajian wrote 8,084 Medicare Part D claims for 1,022 patients. 82% of them were for generic drugs. CMS names the drug for 7,771 of them, across 61 drugs with 11 or more claims each, at $2,014,321 in total drug cost. In 2023, CMS named 7,008 claims across 58 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Serajian for performance year 2024, reported individually. Dr. Serajian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Serajian as offering telehealth. CMS counts 33 procedures of coronary angioplasty and stenting by Dr. Serajian, more than 69% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Serajian. Dr. Serajian's most frequent co-author is Felix J. Rogers, DO.

CMS Open Payments shows 432 general payments to Dr. Serajian from 42 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 77% of the total. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) paid the most, $53,617.